Patents by Inventor James Engert

James Engert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Identification of arsacs mutations and methods of use therefor
    Patent number: 6812333
    Abstract: Isolated spastin genes and fragments thereof, as well as Spastin proteins and fragments thereof are disclosed. Also disclosed are altered forms of spastin, as well as methods for the diagnosis and treatment of neurodegenerative disease.
    Type: Grant
    Filed: October 20, 2000
    Date of Patent: November 2, 2004
    Assignees: Hopital Sainte-Justine, McGill University
    Inventors: Thomas J. Hudson, James Engert, Andrea Richter
  • Very low density lipoprotein receptor polymorphisms and uses therefor
    Publication number: 20020155446
    Abstract: Polymorphic nucleic acid molecules encoding the very low density lipoprotein receptor are described, as well as gene products encoded by these nucleic acid molecules. Allele-specific primers and probes hybridizing to regions flanking or containing these sites are also described, along with methods of use therefor.
    Type: Application
    Filed: March 8, 2001
    Publication date: October 24, 2002
    Applicant: McGill University
    Inventors: James Engert, Marie-Claude Vohl, Carl Brewer, Kenneth Morgan, Daniel Gaudet, Thomas J. Hudson